Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Vericel Corp

VCEL · Nasdaq · CIK 0000887359 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

39 Form 4 transaction lines observed in the same window
20 sales · 19 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
SIEGAL JONATHANPrincipal Accounting Officer
▼▼○▼○▼
MCLAUGHLIN KEVIN FDirector
○○▼○▼
Hopper Jonathan MarkChief Medical Officer
○▼○▼
Flynn Sean C.Chief Legal Officer
○▼○▼
Halpin MichaelChief Operating Officer
○▼○▼
Mara Joseph Anthony JrChief Financial Officer
▼▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 5 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
33Sales
77Other Form 4 lines
47SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING20 sale line(s) · context only
OTHER19 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
5,202,417
Previous report
5,483,102
Avg daily volume
539,786
Days to cover
9.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

110 transaction lines in the latest 365-day window; 618 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-12MCLAUGHLIN KEVIN FSale (S)Common Stock7,000USD 44.53USD 311,710SEC filing ↗
2026-08-12MCLAUGHLIN KEVIN FOption exercise / conversion (M)Common Stock7,000USD 13.05USD 91,350SEC filing ↗
2026-08-03Halpin MichaelSale (S)Common Stock10,000USD 46.84USD 468,400SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-12MCLAUGHLIN KEVIN FSale (S)Common Stock7,000USD 44.53USD 311,710SEC filing ↗
2026-08-12MCLAUGHLIN KEVIN FOption exercise / conversion (M)Common Stock7,000USD 13.05USD 91,350SEC filing ↗
2026-08-03Halpin MichaelSale (S)Common Stock10,000USD 46.84USD 468,400SEC filing ↗
2026-08-03Halpin MichaelOption exercise / conversion (M)Common Stock10,000USD 16.66USD 166,600SEC filing ↗
2026-07-30SIEGAL JONATHANSale (S)Common Stock4,500USD 48.90USD 220,050SEC filing ↗
2026-07-30SIEGAL JONATHANOption exercise / conversion (M)Common Stock4,500USD 31.51USD 141,810SEC filing ↗
2026-06-26SIEGAL JONATHANSale (S)Common Stock2,732USD 44.90USD 122,667SEC filing ↗
2026-06-26SIEGAL JONATHANOption exercise / conversion (M)Common Stock2,500USD 29.82USD 74,550SEC filing ↗
2026-06-26Mara Joseph Anthony JrSale (S)Common Stock5,000USD 44.75USD 223,750SEC filing ↗
2026-06-26Hopper Jonathan MarkSale (S)Common Stock5,000USD 45.00USD 225,000SEC filing ↗
2026-06-26Hopper Jonathan MarkOption exercise / conversion (M)Common Stock5,000USD 29.82USD 149,100SEC filing ↗
2026-06-26Flynn Sean C.Sale (S)Common Stock15,000USD 45.64USD 684,600SEC filing ↗
2026-06-26Flynn Sean C.Option exercise / conversion (M)Common Stock15,000USD 16.25USD 243,750SEC filing ↗
2026-06-18Halpin MichaelSale (S)Common Stock10,000USD 40.24USD 402,400SEC filing ↗
2026-06-18Halpin MichaelOption exercise / conversion (M)Common Stock10,000USD 16.66USD 166,600SEC filing ↗
2026-06-18Flynn Sean C.Sale (S)Common Stock15,000USD 40.21USD 603,150SEC filing ↗
2026-06-18Flynn Sean C.Option exercise / conversion (M)Common Stock15,000USD 16.25USD 243,750SEC filing ↗
2026-06-02Hopper Jonathan MarkSale (S)Common Stock4,375USD 35.00USD 153,125SEC filing ↗
2026-06-02Hopper Jonathan MarkOption exercise / conversion (M)Common Stock4,375USD 16.66USD 72,888SEC filing ↗
2026-05-13MCLAUGHLIN KEVIN FSale (S)Common Stock7,000USD 32.83USD 229,775SEC filing ↗
2026-05-13MCLAUGHLIN KEVIN FOption exercise / conversion (M)Common Stock7,000USD 7.84USD 54,880SEC filing ↗
2026-05-11Wotton Paul KSale (S)Common Stock10,000USD 32.74USD 327,425SEC filing ↗
2026-05-07SIEGAL JONATHANSale (S)Common Stock1,422USD 40.50USD 57,591SEC filing ↗
2026-05-07Mara Joseph Anthony JrSale (S)Common Stock5,000USD 40.50USD 202,500SEC filing ↗
2026-05-06SIEGAL JONATHANSale (S)Common Stock3,433USD 38.00USD 130,454SEC filing ↗
2026-04-29ZERBE ROBERT L MDOption exercise / conversion (M)Common Stock3,200USD —USD —SEC filing ↗
2026-04-29Wotton Paul KOption exercise / conversion (M)Common Stock3,200USD —USD —SEC filing ↗
2026-04-29WRIGHT LISAOption exercise / conversion (M)Common Stock3,200USD —USD —SEC filing ↗
2026-04-29Rubino Alan LOption exercise / conversion (M)Common Stock3,200USD —USD —SEC filing ↗
2026-04-29MCLAUGHLIN KEVIN FOption exercise / conversion (M)Common Stock3,200USD —USD —SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerVCEL
CIK0000887359
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history618 transaction lines from 2020-02-06 to 2026-08-12
0 P purchase lines · 169 S sale lines · 449 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.